A. Reynaud-Bougnoux

发表

A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group.

C. Haie-meder, F. Bertucci, B. Weber, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Abdomino pelvic irradiation after second-look laparotomy for stage III ovarian carcinoma.

G. Calais, G. Body, J. Lansac, 1995, European journal of obstetrics, gynecology, and reproductive biology.

Preoperative or postoperative brachytherapy for patients with endometrial carcinoma stage I and II.

G. Calais, G. Body, J. Lansac, 1990, International journal of radiation oncology, biology, physics.

Lymphadenectomy in the management of endometrial carcinoma stage I and II. Retrospective study of 155 cases.

G. Calais, J. Lansac, P. Descamps, 1990, Clinical oncology (Royal College of Radiologists (Great Britain)).

Toxicity of locoregional radiotherapy in combination with bevacizumab in patients with non-metastatic breast cancer (TOLERAB): Final long-term evaluation

P. Cottu, M. Tanguy, C. Lemanski, 2019, PloS one.

Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study.

P. Cottu, F. Denis, C. Lemanski, 2018, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Squamous cell carcinoma of the base of the tongue: results of treatment in 115 cases.

G. Calais, P. Bougnoux, A. Reynaud-Bougnoux, 1989, The British journal of radiology.

Partial hypoxia as a cause of radioresistance in a human tumor xenograft: its influence illustrated by the sensitizing effect of misonidazole and hyperbaric oxygen.

E. Malaise, M. Guichard, A. Reynaud-Bougnoux, 1986, International journal of radiation oncology, biology, physics.

Disappearance of the in situ component: a criterion predictive of metastasis in breast cancer after local relapse.

G. Calais, B. Chauvet, C. Le Péchoux, 1992, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Radiotherapy with high dose rate brachytherapy boost and concomitant chemotherapy for Stages IIB and III esophageal carcinoma: results of a pilot study.

G. Calais, L. de Calan, P. Bourlier, 1997, International journal of radiation oncology, biology, physics.

Oropharynx carcinoma: irradiation alone versus induction chemotherapy plus irradiation--5 year results.

G. Calais, P. Beutter, A. Reynaud-Bougnoux, 1990, British Journal of Radiology.

Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report.

G. Calais, Y. Pointreau, G. Janoray, 2016, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

The use of MRI in planning radiotherapy for gynaecological tumours

I. Barillot, A. Reynaud-Bougnoux, 2006, Cancer imaging : the official publication of the International Cancer Imaging Society.

Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cm

G. Calais, G. Body, J. Lansac, 1994, Cancer.

Primary chemotherapy and radiosurgical breast-conserving treatment for patients with locally advanced operable breast cancers.

G. Calais, E. Lemarié, G. Body, 1993, International journal of radiation oncology, biology, physics.

Prognostic significance of breast relapse after conservative treatment in node-negative early breast cancer.

G. Calais, B. Chauvet, J. Lansac, 1990, International journal of radiation oncology, biology, physics.

Does short-term androgen depletion add to high-dose radiotherapy (80 Gy) in localized intermediate-risk prostate cancer? Intermediary analysis of GETUG 14 randomized trial (EU-20503/NCT00104741).

B. Dubray, J. Bachaud, S. Guérif, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer.

M. Bollet, P. Cottu, F. Denis, 2015, The British journal of radiology.

[Pregnancy after breast cancer: A literature review].

L. Ouldamer, G. Body, A. Reynaud-Bougnoux, 2019, Presse medicale.

Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications.

G. Calais, P. Garaud, A. de Muret, 1997, International journal of radiation oncology, biology, physics.

Carcinoma of the uterine cervix stage IB and early stage II. Prognostic value of the histological tumor regression after initial brachytherapy.

G. Calais, B. Chauvet, P. Bougnoux, 1989, International journal of radiation oncology, biology, physics.

Enhanced acute toxicity in oropharynx carcinoma treated with radiotherapy and concomitant cisplatin, 5-fluorouracil and mitomycin C.

G. Calais, S. Chapet, A. Reynaud-Bougnoux, 1996, European journal of cancer.

A randomized clinical trial of adjuvant chemotherapy with doxorubicin, ifosfamide, and cisplatin followed by radiotherapy versus radiotherapy alone in patients with localized uterine sarcomas (SARCGYN study). A study of the French Sarcoma Group.

C. Haie-meder, F. Bertucci, I. Ray-Coquard, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.